Etizep Tablets (Etizolam)

• Composition :
  Etizolam 0.25/0.5 mg Tablets.
• Indications :
  For generalized anxiety disorder associated with depression.
• Pharmacodynamics :
  Etizolam is a CNS depressant with anxiolytic, anticonvulsant, sedative-hypnotic and muscle relaxant effects. It acts on the benzodiazepine site of the GABA-A receptor as an agonist to increase inhibitory GABAergic transmission throughout the central nervous system.
• Dosage and administration :
  The recommended dose is 0.25- 0.5 mg times twice daily. Maximum daily dosage: 3mg.
• Contraindications :
  The use of this product is contraindicated in patients with hypersensitivity to any of the ingredients.
• Precautions and warnings :
  Caution should be exercised in patients with history of lung insufficiency, muscle weakness, impaired liver or kidney function, alcoholism or drug addiction.
• Use in pregnancy, lactation & pediatrics :
  There are no adequate and well-controlled studies in human pregnancy, lactation and children. Not rrecomended in pregnancy, lactation and in children
• Drug interactions :
  The risk or severity of adverse effects can be increased when 7-Nitroindazole is combined with Etizolam. The metabolism of Etizolam can be decreased when combined with Abiraterone.
• Adverse reactions :
  The major side effects are drowsiness, muscle weakness, incoordination, headache, confusion, depression, slurred speech and visual disturbances.
• Therapy Area :
  Anxiolytics